Immuron Limited (AU:IMC) has released an update. Immuron Limited announced that all resolutions at its recent Annual General Meeting were ...
Immuron Limited (AU:IMC) has released an update. Immuron Limited has reported a significant 172% increase in global sales, reaching $4.90 ...
Immuron Limited (AU:IMC) has released an update. Immuron Limited announced a change in Director Daniel Pollock’s interest, as 1,600,000 unlisted options lapsed upon expiry on November 13 ...
Immuron Limited (AU:IMC) has released an update. Immuron Limited has announced the issuance of over 5.3 million unquoted performance rights as part of an employee incentive scheme. These ...
MELBOURNE, AUSTRALIA / ACCESSWIRE / November 18, 2024 / Immuron Limited (NASDAQ:IMRN) has one commercial product and two pipeline assets in three clinical programs for the treatment of gut mediated ...
MELBOURNE, Australia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore will be participating in a ...
Immuron Limited (NASDAQ:IMRN), an Australian biopharmaceutical company, announced today that its CEO will participate in the upcoming Maxim Healthcare Conference. The disclosure... Immuron Ltd ...
MELBOURNE, Australia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore will be participating in a fireside ...
Register for the Conference here. Submit Questions for any of the presenting comp MELBOURNE, Australia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise ...
Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore will be participating in a fireside chat at the Maxim Virtual Healthcare Conference on ...
Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce continued strong sales growth (unaudited) of Travelan®, an ...